Two-hour post-dose cyclosporin A levels in adolescent renal transplant recipients in the late post-transplant period
- 1 June 2004
- journal article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 19 (6) , 667-671
Abstract
Although the success of renal transplantation is closely linked to the immunosuppression provided by cyclosporin A (CsA), the best way to monitor the blood levels of CsA is still not clear. Trough CsA levels (C0) are commonly used, but the 2-h post-dose CsA levels (C2) are reported to correlate better with area under the curve. The aim of this study was to evaluate the correlation of C2 levels with allograft function in adolescent renal transplant recipients in the late post-transplant period (6 months after transplantation) compared with C0 levels. The data of 17 adolescent renal transplant recipients (12 males, 5 females) were evaluated retrospectively. The mean age at the time of transplantation was 15.212±2.918 years and the mean follow-up period was 53.172±34.090 months. C0 levels correlated with oral CsA and diltiazem doses, while C2 levels exhibited no correlation. When C2 levels were classified as 0–400, 401–800, and 801–1200 ng/ml, no statistically significant difference was found between these groups with respect to glomerular filtration rate (P=0.830). Although 82% of the patients had C2 beneath the therapeutic level (2 levels could be different from levels in the adult population. Furthermore, the correlation of C2 levels with CsA dose seems to be weaker than in the adult population. Thus, further studies are needed to determine a more reliable predictor for CsA dose monitoring and target blood CsA levels in adolescent patients.Keywords
This publication has 29 references indexed in Scilit:
- Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients1Transplantation, 2003
- Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study.2001
- STIMULATED RESPONSE OF PERIPHERAL LYMPHOCYTES MAY DISTINGUISH CYCLOSPORINE EFFECT IN RENAL TRANSPLANT RECIPIENTS RECEIVING A CYCLOSPORINE+RAPAMYCIN REGIMEN1Transplantation, 2000
- THE TEMPORAL PROFILE OF CALCINEURIN INHIBITION BY CYCLOSPORINE IN VIVO1Transplantation, 1999
- Two‐hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy1Clinical Transplantation, 1998
- Treatment of hypertension in renal allograft patients: does drug selection make a difference?1997
- Cyclosporin Pharmacokinetics in Paediatric Transplant RecipientsClinical Pharmacokinetics, 1997
- Formulation of diltiazem affects cyclosporin-sparing activity.1997
- A RANDOMIZED, PROSPECTIVE MULTICENTER PHARMACOEPIDEMIOLOGIC STUDY OF CYCLOSPORINE MICROEMULSION IN STABLE RENAL GRAFT RECIPIENTS1,2,3Transplantation, 1996
- Lake Louise Consensus Conference on Cyclosporin Monitoring in Organ Transplantation: Report of the Consensus PanelTherapeutic Drug Monitoring, 1995